This platform promotes collaboration among academia, research, and industry, providing essential laboratory technologies that accelerate the development and optimization of protein drugs, nucleic acid therapeutics, and stem cell–based treatments.
1. Protein Drug Engineering and Process Development
• Antibody and protein production
• Antibody efficacy validation
• Antibody humanization and affinity optimization
• Antibody formulation and process optimization
• High-expression mammalian cell line development
• Analytical method development for protein drugs
• Stability testing of biologics
• Collagen scaffold technology platform
• Hybridoma screening for monoclonal antibodies
• Antibody–drug conjugation (ADC)
2. Gene Editing and Cell Modification
• Gene expression, knockout, and knock-in services
3. Nucleic Acid Production and Analysis
• mRNA and saRNA synthesis and activity assays
4. Oncology Research Services
5.Anti-cancer efficacy evaluation using cell-based and mouse tumor models
• Liver cancer stem cell platform for drug screening
6. Autoimmune Disease Models
7. Customized Bioinformatics Services
• NGS and other omics data processing and analysis
• Biomedical database construction
• AI and machine-learning predictive model development
1. Whole-field cell imaging analyzer
2. Ultracentrifuge
3. Flow cytometer
4. Flow cell sorter
5. Automated cell screening system
6. High-sensitivity luminometer
7. ELISA reader
8. Fast protein liquid chromatography (FPLC) system
9. High-performance liquid chromatography (HPLC) system
10. Real-time quantitative PCR system
11. Refrigeration and freezing systems
12. CO₂ incubators
13. Differential scanning calorimeter (DSC)
林美薇 博士
+886-3-5912841
ninety@itri.org.tw